Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 09 08 2023
accepted: 15 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: aheadofprint

Résumé

Merkel cell polyomavirus (MCPyV) is the causative agent of the majority of Merkel cell carcinomas (MCC). The virus has limited coding capacity, with its early viral proteins, large T (LT) and small T (sT), being multifunctional and contributing to infection and transformation. A fundamental difference in early viral gene expression between infection and MCPyV-driven tumorigenesis is the expression of a truncated LT (LTtr) in the tumor. In contrast, sT is expressed in both conditions and contributes significantly to oncogenesis. Here, we identified novel functions of early viral proteins by performing genome-wide transcriptome and chromatin studies in primary human fibroblasts. Due to current limitations in infection and tumorigenesis models, we mimic these conditions by ectopically expressing sT, LT or LTtr, individually or in combination, at different time points. In addition to its known function in cell cycle and inflammation modulation, we reveal a fundamentally new function of sT. We show that sT regulates the type I interferon (IFN) response downstream of the type I interferon receptor (IFNAR) by interfering with the interferon-stimulated gene factor 3 (ISGF3)-induced interferon-stimulated gene (ISG) response. Expression of sT leads to a reduction in the expression of interferon regulatory factor 9 (IRF9) which is a central component of the ISGF3 complex. We further show that this function of sT is conserved in BKPyV. We provide a first mechanistic understanding of which early viral proteins trigger and control the type I IFN response, which may influence MCPyV infection, persistence and, during MCC progression, regulation of the tumor microenvironment.

Identifiants

pubmed: 39110744
doi: 10.1371/journal.ppat.1012426
pii: PPATHOGENS-D-23-01324
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1012426

Informations de copyright

Copyright: © 2024 Ohnezeit et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Denise Ohnezeit (D)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jiabin Huang (J)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ute Westerkamp (U)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Veronika Brinschwitz (V)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Claudia Schmidt (C)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Thomas Günther (T)

Leibniz Institute of Virology, Hamburg, Germany.

Manja Czech-Sioli (M)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Samira Weißelberg (S)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tabea Schlemeyer (T)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jacqueline Nakel (J)

Leibniz Institute of Virology, Hamburg, Germany.

Julia Mai (J)

Institute of Virology, Hannover Medical School, Hannover, Germany.
Institute of Virology, Freiburg, Germany.

Sabrina Schreiner (S)

Institute of Virology, Hannover Medical School, Hannover, Germany.
Institute of Virology, Freiburg, Germany.

Carola Schneider (C)

Leibniz Institute of Virology, Hamburg, Germany.

Caroline C Friedel (CC)

Institute of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany.

Hella Schwanke (H)

Institute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany.

Melanie M Brinkmann (MM)

Institute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany.
Helmholtz Centre for Infection Research, Braunschweig, Germany.

Adam Grundhoff (A)

Leibniz Institute of Virology, Hamburg, Germany.

Nicole Fischer (N)

Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Classifications MeSH